Skip to main content
. 2015 Aug;70(8):563–568. doi: 10.6061/clinics/2015(08)06

Table 3.

Clinical characteristics of NASH-related LC.

Total Female (F) Male (M) p-value (F vs. M)
Number of patients 30 11 19
Age (years) 57.7±14.1 60.6±12.4 55.9±15.0 0.388a
BMI (Kg/m2) 27.2±2.1 27.2±2.2 27.2±2.0 0.965a
Arterial hypertension (%) 11 (36.7) 6 (54.6) 5 (26.3) 0.238b
DM (%) 8 (26.7) 1 (9.1) 7 (36.8) 0.199b
Complications
 Ascites (%) 12 (40.0) 5 (45.5) 7 (36.8) 0.712b
 HCC (%) 0 (0) 0 (0) 0 (0)
 UGB (%) 6 (20.0) 3 (27.3) 3 (15.8) 0.641b
 HRS (%) 0 (0) 0 (0) 0 (0)
 HE (%) 0 (0) 0 (0) 0 (0)
Child-Pugh grading 0.308c
 A (%) 16 (53.3) 5 (45.5) 11 (57.9)
 B (%) 12 (40.0) 4 (36.4) 8 (42.1)
 C (%) 2 (6.7) 2 (18.2) 0 (0)

BMI: body mass index; DM: diabetes mellitus; HCC: hepatocellular carcinoma; UGB: upper gastrointestinal bleeding; HRS: hepatorenal syndrome; HE: hepatic encephalopathy.

p-value determined by a: Student's t test; b: Fisher's exact test; c: the Mann-Whitney U test.